Filing Details

Accession Number:
0001062993-22-022722
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-23 16:10:24
Reporting Period:
2022-11-22
Accepted Time:
2022-11-23 16:10:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603454 Celcuity Inc. CELC Services-Medical Laboratories (8071) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829248 A. Polly Murphy 16305 36Th Avenue N.
Suite 100
Minneapolis MN 55446
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-22 5,000 $9.68 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.31 2032-09-12 10,000 10,000 Direct
Common Stock Stock Option (right to buy) $8.31 2032-09-12 16,300 16,300 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2032-09-12 10,000 10,000 Direct
2032-09-12 16,300 16,300 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.6500 to $9.7000 inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. 2,500 shares vest on each of 9/12/23, 9/12/24, 9/12/25 and 9/12/26.
  3. This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.